Monday, September 23, 2019
- 1:45pm-3:15pm
-
Identification of aberrant circulating miRNAs in Parkinson’s disease plasma samples
Genetics · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Identification of candidates for device-assisted therapy in Parkinson’s disease using Artificial Neural Networks
Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Identification of genetic alterations and SNCA mutation in Parkinson’s disease patients of Coimbatore Population, India
Genetics · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Identification of modifier genes related to G proteins pathways on the motor capacity of a Drosophila melanogaster model of Friedreich’s ataxia
Ataxia · Les Muses, Level 3
- 1:45pm-3:15pm
-
Identifying In-Clinic Wearable Sensor Features that Predict Parkinson’s Disease Severity
Other · Agora 2 West, Level 2
- 1:45pm-3:15pm
-
Identifying the association of depression and distress in Pakistani patients diagnosed with Parkinsonism syndrome
Quality of Life · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Imaging Parkinson’s disease pathology: A comparison between neuromelanin-sensitive MRI, susceptibility weighted imaging and [11C]PE2I DAT PET
Neuroanatomy · Les Muses, Level 3
- 1:45pm-3:15pm
-
Immediate effect of the virtual and augmented reality and neurofunctional physiotherapy on postural control and cognition in patients with Parkinson’s disease: a randomized clinical trial
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Immediate Effects of Non-Motorized Treadmill Training for One Session on Gait and Fall Risk In Parkinson’s Disease
Physical and Occupational Therapy · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Impact of caring for patients with Huntington’s disease on work status
Huntington’s Disease · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 75
- Next Page»